Antiapototic Effect of Tauroursodeoxycholic Acid Protects against Acute Doxorubicin Induced Cardiomyopathy in Rats

Eman R. Abozaid^1, , Amal Al-Shahat Ibrahim² and Nadine A Raafat¹

¹Medical Physiology Department, Zagazig Faculty of Medicine, Egypt

²Human Anatomy and Embryology Department Zagazig Faculty of Medicine, Egypt

Cite this paper:
Eman R. Abozaid, Amal Al-Shahat Ibrahim and Nadine A Raafat. Antiapototic Effect of Tauroursodeoxycholic Acid Protects against Acute Doxorubicin Induced Cardiomyopathy in Rats. American Journal of Medical Sciences and Medicine. 2017; 5(4):71-78. doi: 10.12691/ajmsm-5-4-2

Abstract

Background and purpose: Cardiotoxic carrdiomyopathy mediated by inflammation, oxidative stress lead to apoptosis with subsequently cell damage and heart failure. Tauroursodeoxycholic acid (TUDCA) is a bile acid that have anti-inflammatory and anti-oxidant effect, the current study aimed to examine the effect of administration of TUDCA on doxorubicin induced acute cardiomyopathy and explore the possible mechanism/s. Methods: Cardiomyopathy was induced in rats by single intraperitoneal (ip) injection of doxorubicin (DOX) (15 mg/kg). Results: doxorubicin administration exerted elevated levels of cereatine kinase-MB (CK-MB) and Lactate Dehydrogenase (LDH) in serum, in addition to myocardial TNF-α content, MDA levels, caspase-3, caspase-9 and caspase-12. However decrease in cardiac SOD and catalase content. Histopathological examination of myoendocardial section showed marked degeneration of cardiac muscle, distention of sarcoplasmic reticulum with marked accumulation of collagen fibers. Decrease immunoreactivity to antitroponin antibody. Echocardiography showed reduced LV fractional shortening, ejection fraction, and cardiac output. Treatment with TUDCA (250 mg/kg, ip) for 10 days significantly ameliorated histological changes and decreased the myocardium peroxidative damage in addition to decrease the cardiac markers for apoptosis. Conclusion: TUDCA can protect the heart from cardiotoxic effect of doxurubicin, The protective effects obtained by TUDCA is due to its inhibition of both endoplasmic stress and mitochondrial damage associated with chemotherapy treatment, with antioxidant and antiinflamatory properties. These results confirm the possible use of TUDCA to protect the heart during chemotherapy regimen.

Keywords:
TUDCA cardiomyopathy doxorubicin rats

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Kelishomi, R.B., Ejtemaeemehr S, Tavangar SM, Rahimian R, Mobarakeh JI, Dehpour AR.. Morphine is protective against doxorubicin-induced cardiotoxicity in rat. Toxicology, 2008. 243(1-2): p. 96-104.
[2]	Upadhyay, K.K., Bhatt AN, Mishra AK, Dwarakanath BS, Jain S, Schatz C, Le Meins JF, Farooque A, Chandraiah G, Jain AK, Misra A, Lecommandoux S The intracellular drug delivery and anti-tumor activity of doxorubicin loaded poly (gamma-benzyl L-glutamate)-b-hyaluronan polymersomes. Biomaterials, 2010. 31(10): p. 2882-92.
[3]	Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer. 1973 32(2): 302-14.
[4]	Kazuhiko Saeki, Ichiro Obi, Noriko Ogiku, Munekazu Shigekawa, Toshiaki Imagawa, Takeshi Matsumoto. Doxorubicin directly binds to the cardiac-type ryanodine receptor. Life Sci, 2002. 70(20): p. 2377-89.
[5]	Li, K., Nicholas A. Bruno, Doris L. Slate, Margaret E. Billingham, Suzy V. Torti and Frank M. TortiThrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Circulation, 2006. 113(18): p. 2211-20.
[6]	Takemura G, Fujiwara H. Doxorubicin-induced cardiomyopathy from the cardiotoxic mechanisms to management. Prog Cardiovasc Dis. 2007; 49: 330-352.
[7]	Serafin A, Rosello-Catafau J, Prats N, Gelpi E, Rodes J, Peralta C. Ischemic preconditioning affects interleukin release in fatty livers of rats undergoing ischemia/reperfusion. Hepatology 2004; 39: 688-698.
[8]	Wanderling S, Simen BB, Ostrovsky O, Ahmed NT, Vogen SM, Gidalevitz T, Argon Y. GRP94 is essential for mesoderm induction and muscle development because it regulates insulin-like growth factor secretion. Mol Biol Cell. 2007; 18: 3764-3775.
[9]	Fu HY, Minamino T, Tsukamoto O, Sawada T, Asai M, Kato H, Asano Y, Fujita M, Takashima S, Hori M, Kitakaze M. Overexpression of endoplasmic reticulum-resident chaperone attenuates cardiomyocyte death induced by proteasome inhibition. Cardiovasc Res. 2008; 79: 600-610.
[10]	Nickson P, Toth A, Erhardt P. PUMA is critical for neonatal cardiomyocyte apoptosis induced by endoplasmic reticulum stress. Cardiovasc Res. 2007; 73: 48-56.
[11]	A.E. Elia, S. Lalli, M.R. Monsurro, A. Sagnelli, A.C. Taiello, B. Reggiori, .Tauroursodeoxycholic acid in the treatment of patients with amyotrophic lateral sclerosis Eur J Neurol, 23 (2016), pp. 45-52.
[12]	The Role of Endocrine System in the Inflammatory Process Christian Bowman-Colin, Luis A. Salazar, and Joilson O. Martins Volume 2016, Article ID 6081752, 2 page.
[13]	Sheila Vang, Katie Longley, Clifford J. Steer, and Walter C. Low, Lee YY, Hong SH, Lee YJ, Chung SS, Jung HS. (2010) Tauroursodeoxycholate (TUDCA), chemical chaperone, enhances function of islets by reducing ER stress. Biochem Biophys Res Commun 397: 735-739. View Article Google Scholar
[14]	Chen Y, Liu CP, Xu KF, Mao XD, Lu YB, (2008) Effect of taurine-conjugated ursodeoxycholic acid on endoplasmic reticulum stress and apoptosis induced by advanced glycation end products in cultured mouse podocytes. Am J Nephrol 28: 1014-1022.
[15]	Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, Smith RO, Görgün CZ, Hotamisligil GS. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 2006; 313:1137-1140.
[16]	Y.P. Vandewynckel, D. Laukens, L. Devisscher, A. Paridaens, E. Bogaerts, X. Verhelst,. Tauroursodeoxycholic acid dampens oncogenic apoptosis induced by endoplasmic reticulum stress during hepatocarcinogen exposure Oncotarget, 6 (2015), pp. 28011-28025.
[17]	Eli Muchtar, Lori A. Blauwet, Morie A. Gertz. Restrictive Cardiomyopathy Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy. Circ Res. 2017; 121: 819-837.
[18]	T. Kida, Yoshiki Tsubosaka, Masatoshi Hori Hiroshi Ozaki and Takahisa Murat.Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells Arterioscler. Thromb. Vasc. Biol., 33 (7) (2013), pp. 1663-1669.
[19]	M.S. Desai, Shabbier Z, Taylor M, Lam F, Thevananther S. Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis Hepatology, 51 (6) (2010), pp. 2097-2107.
[20]	Markou T, Cullingford TE, Giraldo A, Weiss SC, Alsafi A, Fuller SJet al. Glycogen synthase kinases 3alpha and 3beta in cardiac myocytes: regulation and consequences of their inhibition. Cell Signal 2008; 20: 206-218.
[21]	S.H. Sheikh Abdul Kadir, et al.Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes PLoS One, 5 (3) (2010), p. e9689.
[22]	Hayward R1, Hydock DS. . Doxorubicin cardiotoxicity in the rat: an in vivo characterization J Am Assoc Lab Anim Sci. 2007 Jul; 46(4): 20-32.
[23]	Honglei Guo, Hongmei Li, Lilu Ling, Yong Gu, and Wei Ding Hindawi Endoplasmic Reticulum Chaperon Tauroursodeoxycholic Acid Attenuates Aldosterone-Infused Renal Injury Mediators of Inflammation Volume 2016, Article ID 4387031, 10 pages.
[24]	Miller FN and Wiegman DL (1977). Anesthesia-induced alteration of small vessel response to norepinephrine. Eur J Pharmacol. 44(4): 331-7.
[25]	Solem LE, Henry TR and Wallace KB: Disruption of mitochondrial calcium homeostasis following chronic doxorubicin administration. Toxicol Appl Pharmacol. 129: 214-239. 1994.
[26]	Sun Y,Oberley LW, Li YA. Simple method for clinical assay of superoxide dismutase. Clin Chem. 1988; 34:497-500.
[27]	El-Sayed el-SM, Mansour AM, Abdul-Hameed MS. Thymol and Carvacrol Prevent Doxorubicin-Induced Cardiotoxicity by Abrogation of Oxidative Stress, Inflammation, and Apoptosis in Rats. J Biochem Mol Toxicol. 2016; 30(1): 37-44.
[28]	Hegazy R, Hegazy A. Hegazy (2015) simplified method of tissue processing (consuming less time and chemicals). Ann. Of Int. Med. & Den. Res, (2): 57-61.
[29]	Bancroft, J. and Gamble, M. (2008): Theory and practice of histological technique (6th Ed), Churchill Livinston, New York Edinburgh, London Pp: 165-175.
[30]	Recai Tunca,1Mahmut Sozmen, Hidayet Erdogan, Mehmet Citil, Erdogan Uzlu, Hasan Ozen,Erhan Gokc¸e (2008) : Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease J Vet Diagn Invest 20:598-605
[31]	Martinez PF, Okoshi K, Zornoff LA, Oliveira SA, Jr., Campos DH, Lima AR, Damatto RL, Cezar MD, Bonomo C, Guizoni DM, Padovani CR, Cicogna AC, Okoshi MP: Echocardiographic detection of congestive heart failure in postinfarction rats. J Appl Physiol 2011; 111:543-551.
[32]	Toko H, Oka T, Zou Y, Sakamoto M, Mizukami M, Sano M, Yamamoto R, Sugaya T, Komuro I: Angiotensin II type 1a receptor mediates doxorubicin-induced cardiomyopathy. Hypertens Res 2002; 25: 597-603.
[33]	Weinstein DM, Mihm MJ, Bauer JA: Cardiac peroxynitrite formation and left ventricular dysfunction following doxorubicin treatment in mice. J Pharmacol Exp Ther 2000; 294: 396-401.
[34]	Robert J: Long-term and short-term models for studying anthracycline cardiotoxicity and protectors. Cardiovasc Toxicol 2007; 7: 135-139.
[35]	Kizaki K, Ito R, Okada M, Yoshioka K, Uchide T, Temma K, Mutoh K, Uechi M, Hara Y: Enhanced gene expression of myocardial matrix metalloproteinases 2 and 9 after acute treatment with doxorubicin in mice. Pharmacol Res 2006; 53: 341-346.
[36]	Bertinchant JP, Polge A, Juan JM, Oliva-Lauraire MC, Giuliani I, Marty-Double C, Burdy JY, Fabbro-Peray P, Laprade M, Bali JP, Granier C, de la Coussaye JE, Dauzat M (2003): Evaluation of cardiac troponin I and T levels as markers of myocardial damage in doxorubicin-induced cardiomyopathy rats, and their relationship with echocardiographic and histological findings. Clin Chim Acta.; 329(1-2): 39-51.
[37]	Sabaheta Hasić, , Radivoj Jadrić, Emina Kiseljaković, Zakira Mornjaković, and Mira Winterhalter-Jadrić (2007): Troponin t and histological characteristics of rat myocardial infarction induced by isoproterenol. Bosn J Basic Med Sci. 7(3): 212-217.
[38]	Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, et al. (2003) Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci U S A 100: 6087-6092.
[39]	Rodrigues CM, Spellman SR, Sola S, Grande AW, Linehan-Stieers C, et al. (2002) Neuroprotection by a bile acid in an acute stroke model in the rat. J Cereb Blood Flow Metab 22: 463-471.
[40]	Li K, Sung RY, Huang WZ, Yang M, Pong NH, Lee SM, Chan WY, Zhao H, To MY,Fok TF, Li CK, Wong YO, Ng PC (2006) Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin. Circulation 113(18): 2211-2220.
[41]	Yuxi Xie, Yonggui He, Zhiliang Cai, Jianhang Cai, Mengyao Xi, Yidong Zhang, and Jinkun Xi Tauroursodeoxycholic acid inhibits endoplasmic reticulum stress, blocks mitochondrial permeability transition pore opening, and suppresses reperfusion injury through GSK-3ß in cardiac H9y c2 cells Am J Transl Res. 2016; 8(11): 4586-4597.
[42]	Kotamraju S, Konorev EA, Joseph J, Kalyanaraman B. Doxorubicin-induced apoptosis in endothelial cells and cardiomyocytes is ameliorated by nitrone spin traps and ebselen. Role of reactive oxygen and nitrogen species. J Biol Chem. 2000; 275: 33585-33592.
[43]	Wang L, Ma W, Markovich R, Chen JW, Wang PH. Regulation of cardiomyocyte apoptotic signaling by insulin-like growth factor I. Circ Res. 1998; 83: 516-522.
[44]	Arola QJ, Saraste A, Pulkki K, Kallajoki M, Parvinen M, Voipio-Pulkki LM. Acute doxorubicin cardiotoxicity involves cardiomyocyte apoptosis. Cancer Res. 2000; 60: 1789-1792.
[45]	Wang S, Leonard SS, Ye J, Ding M, Shi X. The role of hydroxyl radical as a messenger in Cr(VI)–induced p53 activation. Am J Physiol Cell Physiol. 2000; 279: C868-C875.
[46]	Huang C, Zhang Z, Ding M, Li J, Ye J, Leonard SS, Shen HM, Butterworth L, Lu Y, Costa M, Rojanasakul Y, Castranova V, Vallyathan V, Shi X. Vanadate induces p53 transactivation through hydrogen peroxide and causes apoptosis. J Biol Chem. 2000; 275: 32516-32522.
[47]	Gewirtz DA. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics Adriamycin and daunorubicin. Biochem Pharmacol. 1999; 57: 727-741.
[48]	X.H. Duan, J.R. Chang, J. Zhang, B.H. Zhang, Y.L. Li, X. Teng,.Activating transcription factor 4 is involved in endoplasmic reticulum stress-mediated apoptosis contributing to vascular calcification. Apoptosis, 18 (2013), pp. 1132-1144.
[49]	Gupta S, Li S, Abedin MJ, Noppakun K, Wang L, Kaur T, (2012) Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models. PLoS One 7(11): e48950.
[50]	Y. Qinab Y. Wangab O. Liub L. Jiab W. Fanga J. Dub Y. Weia: European Journal of Vascular and Endovascular Surgery Volume 53, Issue 3, March 2017, Pages 337-345.
[51]	Zhong Nan Da Xue Xue Bao Yi Xue Ban. [Tauroursodeoxycholic acid suppresses endoplasmic reticulum stress in pulmonary tissues of intermittent hypoxia mice]. 2015 Nov; 40(11):1165-72.
[52]	Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R,. (2004) Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39: 1563-1573.
[53]	Rodrigues CM, Stieers CL, Keene CD, Ma X, Kren BT. (2000) Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: Evidence for a mitochondrial pathway independent of the permeability transition. J Neurochem 75: 2368-2379.
[54]	Miura T, Nishihara M, Miki T. Drug development targeting the glycogen synthase kinase-3beta (GSK-3beta)-mediated signal transduction pathway: role of GSK-3beta in myocardial protection against ischemia/reperfusion injury. J Pharmacol Sci 2009; 109: 162-167.
[55]	Nishihara M, Miura T, Miki T, Tanno M, Yano T, Naitoh K. Modulation of the mitochondrial permeability transition pore complex in GSK-3beta-mediated myocardial protection. J Mol Cell Cardiol 2007; 43: 564-570.
[56]	Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140.
[57]	Malo A, Krüger B, Seyhun E, Schäfer C, Hoffmann RT, et al. (2010). Tauroursodeoxycholic acid reduces endoplasmic reticulum stress, trypsin activation, and acinar cell apoptosis while increasing secretion in rat pancreatic acini. Am J Physiol Gastrointest Liver Physiol 299: G877-886.